| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/29/2002 | WO2000053735A9 Methods for identifying modulators of synaptic plasticity and cell motility |
| 08/29/2002 | WO2000040715A9 Improved nucleic acid cloning |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000036101A3 An atp-binding cassette protein responsible for cytotoxin resistance |
| 08/29/2002 | WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 08/29/2002 | WO2000032765A9 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 08/29/2002 | WO2000031306A9 Multiplex amplification of short tandem repeat loci |
| 08/29/2002 | WO2000028012A9 THE USE OF β-GLUCOSIDASE TO ENHANCE DISEASE RESISTANCE AND RESISTANCE TO INSECTS IN CROP PLANTS |
| 08/29/2002 | WO2000023569A9 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/29/2002 | WO2000022115A9 Assays for identifying functional alterations in the p53 tumor suppressor |
| 08/29/2002 | WO1999060014A9 Methods and compounds for modulating nuclear receptor coactivator binding |
| 08/29/2002 | WO1999057280A9 Neisseria meningitidis antigens and compositions |
| 08/29/2002 | WO1999045358A8 Identification and expression of human kir5.1 |
| 08/29/2002 | US20020120964 Relates to a glyphosate tolerant cotton plant PV- GHGT07(1445) and to assays for detecting its presence; detection methods of Roundup Ready registered cotton and progeny; DNA from the cotton cell flanking the insertion site and is diagnostic |
| 08/29/2002 | US20020120963 Genes isolated from Arabidopsis coding for proteins essential for seedling growth; using these proteins to discover new herbicides, based on their essentiality for normal growth and development screening assay to identify inhibitors |
| 08/29/2002 | US20020120960 Genetic control of fruit ripening |
| 08/29/2002 | US20020120959 Genetic sequences encoding substrate-specific dihydroflavonol 4-reductase and uses therefor |
| 08/29/2002 | US20020120958 Branched fatty acid lubricating compositions |
| 08/29/2002 | US20020120957 Method for producing branched fatty acids using genetically modified plants |
| 08/29/2002 | US20020120955 Leaf-specific expression of genes in transgenic plants |
| 08/29/2002 | US20020120954 Genetic sequences encoding substrate-specific dihydroflavonol 4-reductase and uses therefor |
| 08/29/2002 | US20020120953 Semicontinuous culture of plant cells in a nutrient medium;monitoring the pH of the medium to monitor expression of an expression product encoded by a polynucleotide under the control of an inducible promoter; antitrypsin |
| 08/29/2002 | US20020120952 Liquid reagent for calcium assay |
| 08/29/2002 | US20020120951 Transgenic mice containing FPR-RS4 gene disruptions |
| 08/29/2002 | US20020120949 Plant protein kinases |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120947 Protein-protein interactions in neurodegenerative disorders |
| 08/29/2002 | US20020120946 Transgenic constructs for studying fibrotic diseases and uses thereof |
| 08/29/2002 | US20020120526 Novel amplicon in the 20q13 region of human chromosome 20 and uses thereof |
| 08/29/2002 | US20020120127 Replica amplification of nucleic acid arrays |
| 08/29/2002 | US20020120126 Making and using immobilized arrays of nucleic acids; improve the efficiency of multiplex polymerase chain reaction (PCR) using arrays of immobilized nucleic acids |
| 08/29/2002 | US20020120125 Polycomb genes from maize - Mez1 and Mez2 |
| 08/29/2002 | US20020120124 Plant cellulose synthases |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020120122 Phosphoserine phosphatase gene of coryneform bacteria |
| 08/29/2002 | US20020120121 Antisense therapy of cancer; Inhibitors of Apoptosis Proteins (IAPs) and an additional related antiapoptotic protein, NAIP; |
| 08/29/2002 | US20020120119 2,5-diketo-D-gluconic acid (2,5-DKG); nucleotides encoding the enzyme; useful in biosynthesis of ascorbic acid |
| 08/29/2002 | US20020120117 Polynucleotide that exhibits urothelial cell-specific transcriptional response element (TRE) activity; adenoviral vectors which replicate preferentially in urothelial cells; treating bladder cancer for example |
| 08/29/2002 | US20020120114 Pesticidal toxins and genes from bacillus laterosporus strains |
| 08/29/2002 | US20020120113 Novel human proteases and polynocleotides encoding the same |
| 08/29/2002 | US20020120112 Lymphoma associated molecules and uses therefor |
| 08/29/2002 | US20020120111 Dwarf5 (dwf5); dwf5 mutants are defective in a step mediated by an S7R (sterol Delta 7 reductase); polynucleotides; use to extend flowering, produce larger leaves or fruit, increase seed production; transgenic plants |
| 08/29/2002 | US20020120107 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 08/29/2002 | US20020120103 17 human secreted proteins |
| 08/29/2002 | US20020120102 Native Arg-Gly-Asp (RGD) motif has been deleted or has been replaced by an amino acid sequence having no integrin- binding activity, or an integrin-binding amino acid sequence other than RGD which contains aspartic acid or glutamic acid |
| 08/29/2002 | US20020120101 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 08/29/2002 | US20020119943 Novel mammalian gene,bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 08/29/2002 | US20020119942 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/29/2002 | US20020119940 Gene expression and delivery systems and uses |
| 08/29/2002 | US20020119929 Fertility; genetic engineering |
| 08/29/2002 | US20020119920 Genetic engineering; diagnosis, therapy |
| 08/29/2002 | US20020119573 Footprinting plasmid |
| 08/29/2002 | US20020119571 Stimulating lymphocytes of graft recipient by cells of graft donor or by cells expressing dominant Major Histocompatability Complex-molecules while transduced with immunmodulatory genes using gene transfer; prevents rejection of allogeneic grafts |
| 08/29/2002 | US20020119570 Mismatch repair of nucleic acids; point mutations; gene expression |
| 08/29/2002 | US20020119566 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 08/29/2002 | US20020119565 Isolation and use of solid tumor stem cells |
| 08/29/2002 | US20020119562 Method for selecting improved vectors |
| 08/29/2002 | US20020119558 Systems for sorting sperm via flow cytometry for sex-specific and low dose efforts at artificial insemination; animal husbandry |
| 08/29/2002 | US20020119554 Arginase II |
| 08/29/2002 | US20020119553 Human secreted protein, ZZP1 |
| 08/29/2002 | US20020119552 Human oncogene induced secreted protein I |
| 08/29/2002 | US20020119551 ppGpp synthetase and expression systems for improved production of protein of interest |
| 08/29/2002 | US20020119549 Nucleotide sequences which code for the RPSL gene |
| 08/29/2002 | US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/29/2002 | US20020119547 58569 and 50111, human proteins and methods of use thereof |
| 08/29/2002 | US20020119546 Isolated polynucleotide that encodes a mevalonate kinase polypeptide |
| 08/29/2002 | US20020119541 Tumor suppressor CAR-1 |
| 08/29/2002 | US20020119540 Novel human ion channel protein and polynucleotides encoding the same |
| 08/29/2002 | US20020119537 Which encode the beta-subunit of RNA polymerase B |
| 08/29/2002 | US20020119536 Microfluidic devices and methods for performing temperature mediated reactions |
| 08/29/2002 | US20020119535 Method for recombining polynucleotides |
| 08/29/2002 | US20020119533 Oligonucleotide anchor and primer, anchor having nucleic acid chemistry which is not substrate for reverse transcriptases and DNA polymerases, and 3'-end not capable of priming DNA synthesis, primer has chemistry which is substrate |
| 08/29/2002 | US20020119529 Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 |
| 08/29/2002 | US20020119528 Nucleotide sequences coding polypeptide for use inthe treatment of leukemia, tumors, infections, autoimmune disease, fibrosis, psoriasis and brain disorders |
| 08/29/2002 | US20020119526 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 08/29/2002 | US20020119525 TAB1 protein and DNA coding therefore |
| 08/29/2002 | US20020119524 Novel molecules of the T129-related protein family and uses thereof |
| 08/29/2002 | US20020119521 Expression vector or use as tools in gene therapy |
| 08/29/2002 | US20020119520 Polypeptide for use in the screening of bactericides and preventing infections |
| 08/29/2002 | US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders |
| 08/29/2002 | US20020119518 Peptide for use in treatment and diagnosis of heart defects |
| 08/29/2002 | US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight |
| 08/29/2002 | US20020119516 Sialylation of saccharides on glycoproteins; obtain glycoprotein, incubate with enzymatic polypeptide, recover adjusted glycoprotein |
| 08/29/2002 | US20020119512 Ups |
| 08/29/2002 | US20020119510 Enzymatic polypeptide for use in screening bactericides |
| 08/29/2002 | US20020119509 Essential fungal genes and their use |
| 08/29/2002 | US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 08/29/2002 | US20020119499 Detecting modulators of membrane protein activities; obtain membrane protein sample, incubtae with modulator, detect adjustment in membrane activity |
| 08/29/2002 | US20020119498 Detection dimerizing test polypeptide; obtain population of genetically engineered cells, express vector, isolate cells expressing desired concentration of reporter molecule |
| 08/29/2002 | US20020119491 Monitoring therapeutic levels of S-adenosylmethionine in fluid sample; obtain sample containing enzymatic polypeptides and glycine, measure concentration of preferential reaction products compare to s-adenosylmethionine |
| 08/29/2002 | US20020119487 Human stem cell antigen 2 |
| 08/29/2002 | US20020119484 Detection and measure of preferential messenger ribonucleic acid; isolate nucleotide sequences from sample, amplify, hybridize to microaray, incubate with probes, detect amount of amplicon hybridized to probe |
| 08/29/2002 | US20020119479 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant GPIIb allele |
| 08/29/2002 | US20020119477 Fusion proteins; genetic engineering |
| 08/29/2002 | US20020119475 Detecting target nucleotide sequence in sample; obtain sample of nucleotide sequences, incubate with protective agent, detecting and recovering protected nucleic acids |
| 08/29/2002 | US20020119474 Kit for use in the treatment of allergies |
| 08/29/2002 | US20020119473 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer |
| 08/29/2002 | US20020119471 Diagnosing allergic contact dermatitis in humans; obtain cells, isolate nucleotide sequences coding interleukins, monitor expression of interleukin polypeptide |